Levetiracetam Altan

Levetiracetam, the active ingredient in Levetiracetam Altan, is an anticonvulsant presented as a pharmaceutical grade for intravenous and oral use. It is employed to manage various seizure types, including partial, generalized tonic‑clonic, and myoclonic seizures, in patients diagnosed with epilepsy. The molecule works by binding to synaptic vesicle protein SV2A, modulating neurotransmitter release and reducing neuronal excitability.

GNH USA supplies Levetiracetam Altan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics, as well as specialized care centers, worldwide.

Levetiracetam is an anticonvulsant used to treat epilepsy by stabilizing neuronal activity.

- Partial seizures: reduces the frequency of focal onset seizures in patients with epilepsy. - Generalized tonic‑clonic seizures: helps control convulsive episodes across the whole brain. - Myoclonic seizures: diminishes rapid, involuntary muscle jerks associated with myoclonic epilepsy.

Levetiracetam is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Somnolence: increased sleepiness or fatigue. - Headache: mild to moderate cranial pain. - Irritability: mood changes or increased agitation. - Nausea: upset stomach or feeling of queasiness.

Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, or anaphylaxis. - Stevens‑Johnson syndrome: rare but serious skin disorder. - Blood dyscrasias: abnormal blood counts such as leukopenia. - Suicidal ideation: thoughts of self‑harm or depression. - Severe depression: marked mood disturbances requiring medical attention.

Before initiating therapy, consider the following precautions.

- Renal impairment: assess kidney function and adjust dose if necessary. - Hepatic impairment: monitor liver enzymes and consider dose modification. - Psychiatric symptoms: observe for mood changes, depression, or suicidal thoughts. - Pregnancy: risk category unknown; discuss potential benefits and risks with a healthcare professional. - Concomitant CNS depressants: may increase sedation or respiratory depression. - Store at room temperature: keep in the original container, protect from moisture and light.

Levetiracetam may interact with other medicines; review the following.

Major Interactions (Avoid): - Carbamazepine: can lower levetiracetam plasma concentrations. - Phenobarbital: may reduce levetiracetam levels, decreasing efficacy. - Phenytoin: can decrease levetiracetam exposure.

Moderate Interactions (Monitor Closely): - Alcohol: additive central nervous system depression. - Other antiepileptic drugs: may require dose adjustments based on therapeutic response. - Renal excretion inhibitors: monitor renal function and consider dose changes.